Scheme S1. Synthesis of deuterated lipophenols: IP-D2-DHA and IP-D4-DHA. a) DCC, DMAP, DCM. b) Et3N-3HF, THF.
1
H NMR (500 MHz, CDCl3): δ = 6. 1H, CHAr), 1H, CHAr), 1H, CHAr), 12H, CHvinylic), 4.44 (septuplet, 3 J(H, H) =6Hz, 1H, CHOiPr), 2.86-2.80 (m, 8H, CH2(bis-allylic), 2.60-2.57 (m, 2H, CH2-CO), 2.51-2.48 (m, 2H, CH2-CH2-CO), 2.10-2.04 (m, 2H,CH2-CH3), 1.30 (d, 3 J(H,H)=6Hz, 6H, CH3(OiPr)), 1.27-1.21 (m, 3H,CHTIPS), 1.09 (d, 3 J(H,H)=7.5Hz, 18H, CH3(TIPS)), 0.97 (t, 3 J(H,H)=8.5Hz, 3H, CH3) ppm; 13 C NMR (125 MHz, CDCl3): δ = 171.4, 159.3, 157.5, 152.1, 132.1, 129.6, 128.7, 128.5, 128.4, 128.4, 128.2, 128.2, 128.0, 128.0, 127.8, 127.1, 106.1, 105.5, 102.4, 70.3, 34.4, 25.8, 25.8, 25.7, 25.7, 25.1 (quint., 1 IP-D4-DHA protected by TIPS: (84 mg, 87% yield) Rf=0.56 (pentane/EtOAc, 95:5); 1 H NMR (500 MHz, CDCl3): δ = 6.29-6.28 (m, 1H, CHAr), 6. 1H, CHAr), 1H, CHAr), 12H, CHvinylic), 4.44 (septuplet, 3 J(H, H) =6Hz, 1H, CHOiPr), 2.86-2.80 (m, 6H, CH2(bis-allylic), 2.60-2.57 (m, 2H, CH2-CO), 2.52-2.48 (m, 2H, CH2-CH2-CO), 2.10-2.05 (m, 2H,CH2-CH3), 1.30 (d, 3 J(H,H)=6Hz, 6H, CH3(OiPr)), 1.27-1.21 (m, 3H,CHTIPS), 1.09 (d, 3 J(H,H)=7.5Hz, 18H, CH3(TIPS)), 0.97 (t, 3 J(H,H)=8.5Hz, 3H, CH3) ppm; 13 C NMR (125 MHz, CDCl3): δ = 171.3, 159.2, 157.5, 152.1, 132.1, 129.6, 128.7, 128.4, 128.4 (2C), 128.2, 128.1, 128.1, 128.0, 127.8, 127.1, 106.1, 105.5, 102.4, 70.2, 34.4, 25.8, 25.7, 25.7, 25.1 (quint., 1 J(C, D) General procedure for the synthesis of deuterated IP-DHA Et3N.3HF (83 µL, 0.51 mmol) was added dropwise to a solution of the deuterated DHA protected by TIPS (0.17 mmol) in dry THF (7.0 mL) at room temperature under inert atmosphere. Additional Et3N.3HF (55 µL, 0.34 mmol) was added after 2.5 h and 5.5 h of reaction. After 7 h, the reaction was quenched by adding EtOAc (20 mL) and H2O (20 mL). The layers were separated and the aqueous one was extracted with 2×10 mL of EtOAc. The combined organic layers were dried over Na2SO4, filtered and the solvents removed under reduce pressure. The residue was purified by chromatography on silica gel (pentane/EtOAc, 95:5 to 85:15) to give the residue which was then purified by preparative HPLC (column Waters SymmetryPrep TM (C18) 7 µm (7.8×300mm); H2O/acetonitrile, 1:9 isocratic; detection 214 nm) to give the deuterated IP-DHA as a pale yellow oil.
IP-D2-DHA: (60 mg, 71% yield) Rf=0.25(pentane/EtOAc, 85:15); 1 H NMR (500 MHz, CDCl3): δ = 6.23-6.22 (m, 1H, CHAr), 6.20-6.17 (m, 1H, CHAr), 6.14-6.13 (m, 1H, CHAr), 5. 12H, CHvinylic) 1, 159.7, 157.4, 152.2, 132.3, 129.9, 128.8, 128.6, 128.5, 128.5, 128.3, 128.3, 128.1 (2C), 127.7, 127.2, 101.9, 101.8, 101.2, 70.5, 34.5, 25.9, 25.8, 25.8, 25.7, 25 .3 (quint., 1 J(C,D)=19.1Hz), 24.9, 23.0, 22.2, 20.8, 14. IP-D4-DHA: (45 mg, 71% yield) Rf=0.23 (pentane/EtOAc, 85:15); 1 H NMR (500 MHz, CDCl3): δ = 6.23-6.22 (m, 1H, CHAr), 6.18-6.17 (m, 1H, CHAr), 6.14-6.13 (m, 1H, CHAr), 5.47-5.30 (m, 12H, CHvinylic), 4.44 (septuplet, 3 J(H,H)=6Hz, 1H, CHOiPr), 2.88-2.80 (m, 6H, CH2(bis-allylic), 2.62- 9, 159.7, 157.3, 152.2, 132.2, 129.8, 128.7, 128.4 (3C), 128.2, 128.1, 128.0, 128.0, 127.6, 127.1, 101.8, 101.7, 101.1, 70.4, 34.4, 25.8, 25.7, 25.7, 25.1 (quint., 1 
II -Choice of oxidative stress conditions of ARPE-19 cells :
-Serum starvation at 1% FBSM was used to provide sufficient and intermediary oxidative stress based on general oxidative status (DCFDA probe) and free radical processes involved in lipid peroxidation (C11-Bodipy 581/591 probe), compared to 2.5 % and 10% FBSM or serum free medium as described in Fig. S1 and S2. -First, the influence of serum in cell medium was evaluated and was found to strongly influence DHA toxicity on cells. DHAs showed toxicity on ARPE-19 cells only in serum-free medium or when using 1% FBSM (fetal bovine serum media), compared to 2.5% or 10% FBSM, where no DHA toxicity was observed up to a final concentration of 110 µM. FBS mediated the protective effect against pro-oxidant conditions, and was responsible for a decrease in global oxidative status ( Fig. S1 , DCFDA probe 3 ) and in lipid peroxidation status ( Fig. S2) . Figure S1 . Intensity of fluorescence observed during DCFDA oxidation by radical species on ARPE-19 cells in different medium (FACS analysis). Radical reactive species able to oxidize DCFDA were measured in ARPE-19 cells. The cell permeant reagent DCFDA is deacetylated by cellular esterases to dichlorofluorescein (DCFH), which can be oxidized by several radical reactive species (peroxyl, alkoxyl, NO2 . , carbonate, HO . , …) 3 into the fluorophore 2',7'-dichlorofluorescein (DCF). ARPE-19 cells were plated into 2 cm 2 wells (2×10 5 cells/well) and cultured for 24 h to reach confluence before drug treatment. The cell cultures were incubated with 2 µM of DCFDA for 40 min in serum free medium. The cells were rinsed and incubated in different media without phenol red (serum free, 1% FBSM, 2.5% FBSM or 10% FBSM) for 4 h followed by the FACS analysis. The data are expressed as the percentage of treated cells with serum free medium (Ø FBSM) and presented as means ± SD (n = 1 experiment, each condition in triplicate). 2',7'-dichlorofluorescin diacetate (DCFDA) was purchased from Abcam and dissolved in DMSO to prepare stock solution at 20 mM.
( Figure S2 . Intensity of C11-BODIPY fluorescence on ARPE-19 cells in different medium (FACS analysis). ARPE-19 cells were plated into 2 cm 2 wells (2×10 5 cells/well) and cultured for 24 h to reach confluence. The cells were always rinsed with the corresponding described medium before treatment. For all the experiments, DMEM/Ham F12 without phenol red was used. The cell cultures were incubated with 5 µM of C11-BODIPY 581/591 for 30 min in serum free medium. The cells were rinsed and incubated in the different media (serum free, 1% FBSM, 2.5% FBSM or 10% FBSM) for 24 h followed by the FACS analysis. The data are expressed as the percentage of treated cells with serum free medium (Ø FBSM) and presented as means ± SD (n = 1 experiment, each condition in triplicate).
-H2O2 concentration used in toxicity assay (600 µM) lead to 60-70% of mortality (Fig. S3) , whereas the one used during the comparison of lipid peroxidation status (400 µM) evaluate by FACS methodology, avoid important cell mortality and provide a plateau in global oxidative status ( Fig. S3 and S4) . 
III-Validation of FACS analysis conditions
-Light intensities of 5 000 to 20 0000 lux for the photobleaching stress were also tested, and 5 000 lux was efficient to observed an increase of oxidized C11-Bodipy 581/591 (Fig. S5) . . ARPE-19 cells were plated into 2 cm 2 wells (2×10 5 cells/well) and cultured for 24 h to reach confluence. The cells were rinsed with 1% FBSM before treatment. For all the experiments, DMEM/Ham F12 without phenol red was used. The cell cultures were treated with 1% FBSM containing DHA at 50 μm for 24 h and then rinsed with 1% FBSM before the incubation of 5 µM C11-BODIPY 581/591 for 30 min. The cells were rinsed and exposed to a white LED lamp with different intensities (5 000, 10 000 or 20 000 lux) at room temperature during 1 h followed by the FACS analysis. The data are expressed as the percentage of untreated cells (CTL Ø) and presented as means ± SD (n = 1 experiment, each condition in triplicate).
-
The pre-treatment with natural DHA had no impact on the probe incorporation (Fig. S6) FACS analysis) . ARPE-19 cells were plated into 2 cm 2 wells (2×10 5 cells/well) and cultured for 24 h to reach confluence. The cells were always rinsed with 1% FBSM before treatment. For all the experiments DMEM/Ham F12 without phenol red was used. A part of the cells was treated with 1% FBSM containing DHA at 50 μm for 24 h, and then rinsed with media before the incubation of 5 µM C11-BODIPY 581/591 for 30 min. The other part of the cells was incubated with 1% FBSM containing 5 µM C11-BODIPY 581/591 for 30 min, then rinsed and treated with 1% FBSM containing DHA at 50 μm for 24 h. All the cells were finally rinsed and incubated in 1% FBSM during 24 h followed by the FACS analysis. The data are expressed as the percentage of untreated cells (CTL Ø) and presented as means ± SD (n = 1 experiment, each condition in triplicate).
IV -sample treatment of oxidase DHAs: extraction yield
× 100 = (%)
Extraction yield ± SD (%)
Internal standard C21-15-F 2t -IsoP 83,23 ± 12,21 Neuroprostanes 4(RS)-F 4t -NeuroP 100,48 ± 22,93 Figure S7 . Protocol and analysis of extraction yield. The preparation of the sample of oxidized natural DHA was validated through the evaluation of the yield of extraction for the SPE protocol. For this protocol, a monoplicat of the following solution was prepared: 1) Two samples of oxidized natural DHA (n = 2) were spiked with 4 ng of IS stock solution and with 3.2 ng of standards solution, and were extracted as previously described; 2) Two samples of oxidized natural DHA (n=2) were extracted then spiked with 4 ng of IS stock solution and with 3.2 ng of standards solution. All sets of two samples were analyzed once using the LC-MS/MS system. The yield of extraction was calculated as the percentage difference between peaks areas of standards in 1) pre-spiked and 2) post-spiked samples with each set of data.
V -MS/MS analysis of 4-F4t-NeuroP(s)
Standards Table S1 . MRM transitions, retention times (RT) and voltages (DP: declustering potential, EP: entrance potential, CE: collision energy, CXP: collision cell exit potential) used for the detection and determination of standards (IS)
IsoP (C21-15-F2t-IsoP) and NeuroPs (4(RS)-F4t-NeuroP). Figure S8 . Influence of deuterium incorporation on 15s-LOX kinetics: Michaelis-Menten kinetics V(0) (initial reaction rates) derived from, UV analysis performed at 270 nm. The four investigated DHAs were tested at 0.02mM, 0.04mM, 0.1mM and 0.2mM, The 15-sLOX enzyme at 0.053 mg/mL. All V(0) values were determined in triplicate and the average was used for the determination of Michaelis-Menten kinetics of table 2.
